Achieving a malaria-free world presents exciting scientific challenges as well as
overwhelming health, equity, and economic benefits. WHO and countries are setting …

Poor-quality antimalarial drugs lead to drug resistance and inadequate treatment, which
pose an urgent threat to vulnerable populations and jeopardise progress and investments in …

The emergence of resistance to former first-line antimalarial drugs has been an unmitigated
disaster. In recent years, artemisinin class drugs have become standard and they are …

Despite intensive research extending back to the 1930s, when the first synthetic antimalarial
drugs made their appearance, the repertoire of clinically licensed formulations remains very …

Background A number of recent malaria studies have used identity by descent (IBD) to study
epidemiological processes relevant to malaria control. In this paper, a software package …

BACkground Plasmodium resistance to antimalarial medicines is one of the major obstacles
in the fight against malaria. Comprehensive, up-to-date understanding of the scope of …

With the rapidly increasing abundance and accessibility of genomic data, there is a growing
interest in using population genetic approaches to characterize fine-scale dispersal of …

The spread of drug-resistant Plasmodium falciparum malaria has been a major impediment
to malaria control and threatens prospects for elimination. We recently demonstrated the …

Background Although the molecular basis of resistance to a number of common antimalarial
drugs is well known, a geographic description of the emergence and dispersal of resistance …

Background Plasmodium falciparum malaria remains a major public health problem. A vital
component of malaria control rests on the availability of good quality artemisinin-derivative …